EUA
New York SARS-CoV Microsphere Immunoassay for Antibody Detection
FDA Emergency Use Authorization · Wadsworth Center, New York State Department of Health · Apr 30, 2020
Key facts
| Product | New York SARS-CoV Microsphere Immunoassay for Antibody Detection |
|---|---|
| Company | Wadsworth Center, New York State Department of Health |
| Product type | Total Antibody, FMIA |
| Date | Apr 30, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: